Lol there really is no target. It depends on a lot of things. The recent article points out in 2012 the market for pancreatic cancer is worth over 520,000,000... If were baught out by whomever they will discuss a value, or we could become our own bio pharma "big player" up there with celgene and Lilly. just remeber, Nuvilex's Cell-in-a-Box is not just limited to pancreatic cancer! the technology could eventually involve other treatments, they are just focusing on pancreatic cancer for the purpose of it's trials. A lot of people don't realize this. There is just so much potential here, Dr. Van Hoff is the best in the business (literally!) and he's on our team. Do your DD and see how the company has become to where it's at, how these big players got involved, and come up with your own opinions. IMO, this is a goldmine not only for investors but pancreatic cancer patients. Good luck in your ventures. $NVLX
News 
Market Data 
Discover 
